Cited by 161Pharmacological Effects and Toxicity StudiesEpilepsy research and treatmentFetal and Pediatric Neurological Disorders

Child development following in utero exposure: Levetiracetam vs sodium valproate

Open access
Shallcross, R., Bromley, R.L., Irwin, B., Bonnett, L.J., Morrow, J., Baker, G.A.·2011·Neurology

Abstract

OBJECTIVE: Children born to women with epilepsy (WWE), exposed in utero to levetiracetam (LEV, n = 51), were assessed for early cognitive development and compared to children exposed to sodium valproate in utero (VPA, n = 44) and a group of children representative of the general population (n = 97). METHODS: Children were recruited prospectively from 2 cohorts in the United Kingdom and assessed using the Griffiths Mental Development Scale (1996), aged <24 months. Information regarding maternal demographics were collected and controlled for. This is an observational study with researchers not involved in the clinical management of the WWE. RESULTS: On overall developmental ability, children exposed to LEV obtained higher developmental scores when compared to children exposed to VPA (p < 0.001). When compared, children exposed to LEV did not differ from control children (p = 0.62) on overall development. Eight percent of children exposed to LEV in utero fell within the below average range (DQ score of <84), compared with 40% of children exposed to VPA. After controlling for maternal epilepsy and demographic factors using linear regression analysis, exposure to LEV in utero was not associated with outcome (p = 0.67). Conversely, when compared with VPA exposure, LEV exposure was associated with higher scores for the overall developmental quotient (p < 0.001). CONCLUSION: Children exposed to LEV in utero are not at an increased risk of delayed early cognitive development under the age of 24 months. LEV may therefore be a preferable drug choice, where appropriate, for WWE prior to and of childbearing age.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3182088297

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [13]13. Russell A, Craig J, Morrison P, et al. UK Epilepsy and Pregnancy Group. Epilepsia 2004;45:1467.
  2. [19]19. Bromley RL, Gummery A, Shallcross R, et al. IQ, memory, language and attention in children exposed to antiepi- leptic drugs in utero: preliminary outcomes at 6 years of age. Epilepsia 2009;50:491. Abstract.

Cited by

Sorted by citations

Authors
Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A.
Affiliations
University of Liverpool (GB)
Venue
Neurology
Published
2011-01-25
Volume
76
Issue
4
Pages
383-389
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2031334993
Cited by
161
References
26
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 12 · 2015: 14 · 2014: 17 · 2013: 21 · 2012: 24
FWCI
20.14
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
  • Bristol Research (University of Bristol) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
Funders
  • Pfizer
  • GlaxoSmithKline
  • Epilepsy Research UK
  • Research Councils UK
  • Eisai
  • National Institutes of Health
  • Medical Research Council
  • National Institute of Neurological Disorders and Stroke (R01NS038455)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
Keywords
maternal epilepsy, prenatal drug exposure, levetiracetam, valproic acid, child cognitive development, developmental quotient, antiepileptic drugs, pregnancy, Griffiths Mental Development Scales
MeSH terms
Levetiracetam, Anticonvulsants, Child Development, Child, Preschool, Cognition, Epilepsy, Female, Humans, Infant, Maternal-Fetal Exchange, Piracetam, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Retrospective Studies, Valproic Acid, Maternal Exposure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review